Table 1.
Sequences of primers used in this study
| Forward | Reverse | |
|---|---|---|
| GAPDH | TGGCAAAGTGGAGATTGTTGCC | AAGATGGTGATGGGCTTCCCG |
| CD11c | CTGGATAGCCTTTCTTCTGCTG | GCACACTGTGTCCGAACTCA |
| CD32 | AATCCTGCCGTTCCTACTGATC | GTGTCACCGTGTCTTCCTTGAG |
| CD86 | TTGTGTGTGTTCTGGAAACGGAG | AACTTAGAGGCTGTGTTGCTGGG |
| IFN‐γ | GATGCATTCATGAGTATTGCCAAGT | GTGGACCACTCGGATGAGCTC |
| IL‐1β | TTGACGGACCCCAAAAGAT | GAAGCTGGATGCTCTCATCAG |
| IL‐4 | GGTCTCAACCCCCAGCTAGT | GCCGATGATCTCTCTCAAGTGAT |
| IL‐5 | TGCCTGGAGCAGCTGGAT | GTGGCTGGCTCTCATTCACA |
| IL‐6 | AGGATACCACTCCCAACAGAC | CAAGTGCATCATCGTTGTTCA |
| IL‐12 | AAATGAAGCTCTGCATCCTGC | TCACCCTGTTGATGGTCACG |
| IL‐17a | CTCCAGAAGGCCCTCAGACTAC | GGGTCTTCATTGCGGTGG |
| IL‐23 | TGGCATCGAGAAACTGTGAGA | TCAGTTCGTATTGGTAGTCCTGTTA |
| iNOS | CCCTTCAATGGTTGGTACATGG | ACATTGATCTCCGTGACAGCC |
| MHC Class II | GAGGCTCAACTTGTCCCAAAAC | GCAGCCGTGAACTTGTTGAAC |
| TNF‐α | GAACTCCAGGCGGTGCCTAT | TCGGCTGGCACCACTAGTTG |